Contrary to the previous findings made by Jin et al. [15], our results showed that MTHFR C677T polymorphism was not associated with HCC risk not only in the overall population but also in the subgroup analyses stratified by ethnicity and source of controls. The gene discussed is MTHFR; the disease is hepatocellular carcinoma.